晶状体蛋白γ1抗体

Quantity size:

0.2ml

Concentration:

1mg/ml晶状体蛋白γ1抗体   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, 晶状体蛋白γ1抗体making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking 晶状体蛋白γ1抗体connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008]

晶状体蛋白γ1抗体Also known as:

CRY g A; CRYG1; CRGA_HUMAN; CRYG5; Crystallin, gamma 1; Crystallin, gamma A; Gamma A crystallin; Gamma crystallin 5; Gamma crystallin A;

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Horse, Rabbit, .

●

Immunogen: KLH conjugated synthetic peptide derived from human CRYGA.

●

Predicted Molecular Weight: 21kDa.

晶状体蛋白γ1抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl218Rb51转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)

kl218Si01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)

kl220Bo01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl220Ca01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl220Eq01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl220Hu01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl220Mu01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl220Po01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl220Ra01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)

kl221Mu01转录因子20(TCF20)多克隆抗体Polyclonal Antibody to Transcription factor 20 (TCF20)

kl222Bo01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Ca01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Eq01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Ga01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Hu01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Mu01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Po01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)

kl222Ra01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)